Topical Remibrutinib Attenuates LL37-Induced Rosacea-Like Dermatitis by Inhibiting BTK Activation, NF-κB Signaling and Mast Cell Activation
Journal of Inflammation Research · 2026-10 · Volume 19 · 1-14
DOI: 10.2147/jir.s643728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-10. Verfasst von Wangchao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, 261000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, 261000, People's Republic of China.
- School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, 261000, People's Republic of China.
ORCID-Profile: Wangchao Li, Hua Liu, Qingsong Ma, Dong Zhang, Weiyuan Ma
Zitieren
APA
Li, W., Fan, H., Liu, H., Ma, Q., Liu, C., Zhang, D., & Ma, W. (2026). Topical Remibrutinib Attenuates LL37-Induced Rosacea-Like Dermatitis by Inhibiting BTK Activation, NF-κB Signaling and Mast Cell Activation. Journal of Inflammation Research, Volume 19, 1-14. https://doi.org/10.2147/jir.s643728
Vancouver
Li W, Fan H, Liu H, Ma Q, Liu C, Zhang D, et al. Topical Remibrutinib Attenuates LL37-Induced Rosacea-Like Dermatitis by Inhibiting BTK Activation, NF-κB Signaling and Mast Cell Activation. Journal of Inflammation Research. 2026;Volume 19:1-14. doi:10.2147/jir.s643728
BibTeX
@article{Li2026,
author = {Li, Wangchao and Fan, Huiping and Liu, Hua and Ma, Qingsong and Liu, Chengqi and Zhang, Dong and Ma, Weiyuan},
title = {Topical Remibrutinib Attenuates LL37-Induced Rosacea-Like Dermatitis by Inhibiting BTK Activation, NF-κB Signaling and Mast Cell Activation},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/jir.s643728}
}
EUVIMED